vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and Energy Recovery, Inc. (ERII). Click either name above to swap in a different company.

Energy Recovery, Inc. is the larger business by last-quarter revenue ($66.9M vs $45.1M, roughly 1.5× Amarin Corp plc). Energy Recovery, Inc. runs the higher net margin — 40.2% vs -23.3%, a 63.5% gap on every dollar of revenue. On growth, Amarin Corp plc posted the faster year-over-year revenue change (7.0% vs -0.3%). Over the past eight quarters, Energy Recovery, Inc.'s revenue compounded faster (8.1% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Energy Recovery Inc. is an American manufacturer of energy recovery devices for water and CO2 refrigeration industries.

AMRN vs ERII — Head-to-Head

Bigger by revenue
ERII
ERII
1.5× larger
ERII
$66.9M
$45.1M
AMRN
Growing faster (revenue YoY)
AMRN
AMRN
+7.3% gap
AMRN
7.0%
-0.3%
ERII
Higher net margin
ERII
ERII
63.5% more per $
ERII
40.2%
-23.3%
AMRN
Faster 2-yr revenue CAGR
ERII
ERII
Annualised
ERII
8.1%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
ERII
ERII
Revenue
$45.1M
$66.9M
Net Profit
$-10.5M
$26.9M
Gross Margin
67.2%
Operating Margin
35.5%
46.8%
Net Margin
-23.3%
40.2%
Revenue YoY
7.0%
-0.3%
Net Profit YoY
33.0%
14.7%
EPS (diluted)
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
ERII
ERII
Q1 26
$45.1M
Q4 25
$49.2M
$66.9M
Q3 25
$49.7M
$32.0M
Q2 25
$72.7M
$28.1M
Q1 25
$42.0M
Q4 24
$62.3M
$67.1M
Q3 24
$42.3M
$38.6M
Q2 24
$67.5M
$27.2M
Net Profit
AMRN
AMRN
ERII
ERII
Q1 26
$-10.5M
Q4 25
$-1.2M
$26.9M
Q3 25
$-7.7M
$3.9M
Q2 25
$-14.1M
$2.1M
Q1 25
$-15.7M
Q4 24
$-48.6M
$23.5M
Q3 24
$-25.1M
$8.5M
Q2 24
$1.5M
$-642.0K
Gross Margin
AMRN
AMRN
ERII
ERII
Q1 26
Q4 25
47.1%
67.2%
Q3 25
44.7%
64.2%
Q2 25
69.2%
64.0%
Q1 25
59.8%
Q4 24
-15.4%
70.2%
Q3 24
38.5%
65.1%
Q2 24
63.4%
64.6%
Operating Margin
AMRN
AMRN
ERII
ERII
Q1 26
35.5%
Q4 25
-12.9%
46.8%
Q3 25
-22.4%
11.4%
Q2 25
-22.0%
5.3%
Q1 25
-39.9%
Q4 24
-84.3%
38.2%
Q3 24
-59.5%
18.3%
Q2 24
-0.8%
-7.4%
Net Margin
AMRN
AMRN
ERII
ERII
Q1 26
-23.3%
Q4 25
-2.5%
40.2%
Q3 25
-15.6%
12.1%
Q2 25
-19.4%
7.3%
Q1 25
-37.4%
Q4 24
-78.0%
35.0%
Q3 24
-59.4%
22.0%
Q2 24
2.3%
-2.4%
EPS (diluted)
AMRN
AMRN
ERII
ERII
Q1 26
Q4 25
$0.00
$0.49
Q3 25
$-0.02
$0.07
Q2 25
$-0.03
$0.04
Q1 25
$-0.04
Q4 24
$-0.12
$0.40
Q3 24
$-0.06
$0.15
Q2 24
$0.00
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
ERII
ERII
Cash + ST InvestmentsLiquidity on hand
$307.8M
$75.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$206.2M
Total Assets
$645.8M
$231.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
ERII
ERII
Q1 26
$307.8M
Q4 25
$302.6M
$75.2M
Q3 25
$286.6M
$70.4M
Q2 25
$298.7M
$79.5M
Q1 25
$281.8M
Q4 24
$294.2M
$78.0M
Q3 24
$305.7M
$118.6M
Q2 24
$306.7M
$101.0M
Stockholders' Equity
AMRN
AMRN
ERII
ERII
Q1 26
Q4 25
$459.3M
$206.2M
Q3 25
$458.9M
$180.8M
Q2 25
$464.9M
$185.2M
Q1 25
$473.7M
Q4 24
$486.2M
$210.0M
Q3 24
$531.4M
$233.9M
Q2 24
$551.9M
$218.5M
Total Assets
AMRN
AMRN
ERII
ERII
Q1 26
$645.8M
Q4 25
$670.8M
$231.5M
Q3 25
$659.8M
$209.6M
Q2 25
$670.1M
$212.3M
Q1 25
$655.7M
Q4 24
$685.3M
$242.8M
Q3 24
$750.6M
$262.7M
Q2 24
$799.9M
$249.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
ERII
ERII
Operating Cash FlowLast quarter
$7.1M
Free Cash FlowOCF − Capex
$6.4M
FCF MarginFCF / Revenue
9.6%
Capex IntensityCapex / Revenue
1.0%
Cash ConversionOCF / Net Profit
0.26×
TTM Free Cash FlowTrailing 4 quarters
$15.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
ERII
ERII
Q1 26
Q4 25
$15.3M
$7.1M
Q3 25
$-12.7M
$-3.1M
Q2 25
$16.6M
$4.1M
Q1 25
$-12.5M
Q4 24
$-13.3M
$9.0M
Q3 24
$-2.4M
$-3.0M
Q2 24
$-2.7M
$8.1M
Free Cash Flow
AMRN
AMRN
ERII
ERII
Q1 26
Q4 25
$6.4M
Q3 25
$-3.5M
Q2 25
$4.0M
Q1 25
Q4 24
$8.9M
Q3 24
$-3.2M
Q2 24
$7.9M
FCF Margin
AMRN
AMRN
ERII
ERII
Q1 26
Q4 25
9.6%
Q3 25
-10.9%
Q2 25
14.3%
Q1 25
Q4 24
13.2%
Q3 24
-8.2%
Q2 24
28.9%
Capex Intensity
AMRN
AMRN
ERII
ERII
Q1 26
Q4 25
1.0%
Q3 25
1.1%
Q2 25
0.5%
Q1 25
Q4 24
0.2%
Q3 24
0.4%
Q2 24
0.7%
Cash Conversion
AMRN
AMRN
ERII
ERII
Q1 26
Q4 25
0.26×
Q3 25
-0.81×
Q2 25
2.02×
Q1 25
Q4 24
0.38×
Q3 24
-0.35×
Q2 24
-1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

ERII
ERII

Water Segment$38.6M58%
Other$11.0M16%
Original Equipment Manufacturer$10.6M16%
Aftermarket$6.6M10%

Related Comparisons